Growth and leadership Revenue range of $50M-$100M and recent executive hires in sales and marketing indicate BioZyme is scaling its commercial capabilities and expanding market reach. Target opportunities include enterprise-wide nutrition programs, channel partnerships, and enhanced distributor networks to accelerate growth.

Product expansion Recent launch of Vitalize Blazin Pellets and ongoing emphasis on Amaferm-based formulations suggest ongoing product line growth. Sales opportunities exist in stocking new pellet products, cross-selling with existing VitaFerm and Sure Champ brands, and co-marketing with formulator partners.

Global reach BioZyme serves markets across North America, South America, Europe, Asia, and the Middle East. Key selling points include international distribution, regulatory support, and region-specific formulation needs, offering potential for multi-region contracts and export-led partnerships.

R&D and credibility Amaferm prebiotic with 175+ published studies reinforces proof-of-effectiveness. This strength can be leveraged in consultative selling, trade-up opportunities to premium gut-health solutions, and customer education programs to drive higher adoption and retention.

Talent signals Recent hires across sales, marketing, formulation, and national distribution indicate investment in market expansion and customer-facing capabilities. Use this to position BioZyme as a committed partner with dedicated support, onboarding programs, and responsive technical assistance for large-scale accounts.